Skip to main content
FinSpry Logo
FinSpry
PAHC logo
PAHC
(NASDAQ)
Phibro Animal Health Corporation
$55.52-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Phibro Animal Health (PAHC) Stock Price & Financial Analysis

Phibro Animal Health Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$51.69 - $55.63
52-Week High$57.62
52-Week Low$16.16
Open$53.16
Volume246.52K
Average Volume (3M)246.52K
Market Cap2.27B
Shares Outstanding40.96M
P/E Ratio (TTM)24.35
Forward P/E12.18
Price to Sales (P/S)1.53
Price to Book (P/B)6.75
EV/EBITDA13.37
Revenue (TTM)1.46B
Net Income (TTM)92.09M
Free Cash Flow (TTM)47.29M
EPS (TTM)$2.25
Profit Margin6.29%
Operating Margin11.53%
Return on Equity (ROE)27.71%
Debt to Equity2.20
50-Day MA$49.64
200-Day MA$39.59
52-Week Change149.25%
Annual Dividend$0.48
Dividend Yield0.88%
Payout Ratio21.35%
Last Dividend Ex-DateMar 4, 2026

Frequently Asked Questions About Phibro Animal Health

What is the current stock price for PAHC?

As of the latest trading session, PAHC stock trades at $55.52. The 52-week range is $16.16–$57.62, with a day range of $51.69–$55.63.

What is the P/E ratio for PAHC?

Phibro Animal Health's trailing P/E ratio is 24.4, meaning investors pay $24.4 for every $1 of annual earnings. The forward P/E is 12.2, reflecting analyst expectations for future earnings. Phibro Animal Health operates in the Healthcare sector.

Does PAHC pay dividends?

Yes, Phibro Animal Health pays a 0.88% annual dividend yield ($0.48 per share). The payout ratio is 21.4%. The last ex-dividend date was 2026-03-04.

What do analysts recommend for PAHC?

Analyst ratings and recommendations for PAHC are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of PAHC?

Phibro Animal Health's market capitalization is $2.27B, classifying it as a mid-cap company. Phibro Animal Health operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.